US HB1352 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on March 3 2023 - 25% progression
Action: 2023-12-06 - Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 3 2023 - 25% progression
Action: 2023-12-06 - Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.
Text: Latest bill text (Introduced) [PDF]
Summary
To require the Secretary of Health and Human Services to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.
Title
Increasing Access to Biosimilars Act of 2023
Sponsors
| Rep. Richard Hudson [R-NC] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-12-06 | House | Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0. |
| 2023-12-05 | House | Committee Consideration and Mark-up Session Held |
| 2023-11-15 | House | Forwarded by Subcommittee to Full Committee by Voice Vote. |
| 2023-11-15 | House | Subcommittee Consideration and Mark-up Session Held |
| 2023-03-10 | House | Referred to the Subcommittee on Health. |
| 2023-03-03 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2023-03-03 | House | Introduced in House |
Same As/Similar To
SB3934 (Related) 2024-03-14 - Read twice and referred to the Committee on Finance.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/1352/all-info |
| Text | https://www.congress.gov/118/bills/hr1352/BILLS-118hr1352ih.pdf |
